Morgan Stanley Maintains Equal-Weight on Moderna, Raises Price Target to $89

Benzinga · 3d ago
Morgan Stanley analyst Terence Flynn maintains Moderna (NASDAQ:MRNA) with a Equal-Weight and raises the price target from $39 to $89.